- Home
- IOVA
IOVA
Iovance Biotherapeutics Inc.
as 04-18-2025 1:38pm EST
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SAN CARLOS |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $18.22 | AVG Volume (30 days): | 9.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.70 - $14.23 | Next Earning Date: | 05-08-2025 |
| Revenue: | $164,070,000 | Revenue Growth: | 13698.99% |
| Revenue Growth (this year): | 181.77% | Revenue Growth (next year): | 64.89% |
Latest Iovance Biotherapeutics Inc. News
IOVA Breaking Stock News: Dive into IOVA Ticker-Specific Updates for Smart Investing
Motley Fool
3 hours ago
This Biotech Stock Could Be the Best Investment of the Decade
Insider Monkey
19 hours ago
Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?
GlobeNewswire
19 hours ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Insider Monkey
3 days ago
Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Motley Fool
5 days ago
Is Iovance Biotherapeutics a Millionaire-Maker?
Insider Monkey
10 days ago
Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple
Motley Fool
12 days ago
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Simply Wall St.
15 days ago
Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction
Compare IOVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IOVA Iovance Biotherapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.